Nur Hafizah Annezah Utuh is a Malaysian clinical pharmacy researcher and pharmacogenomics advocate working to advance precision medicine and more equitable access to healthcare. She graduated from Universiti Sains Malaysia (USM) in 2023 with a First-Class Bachelor of Pharmacy and is now pursuing a PhD in Clinical Pharmacy, specialising in pharmacogenomics.
Her PhD research looks at how a patient’s genetic makeup can help doctors choose the most suitable blood-thinning medication for coronary artery disease. Specifically, she studies how differences in the CYP2C19 gene affect patients’ responses to antiplatelet medicines used to prevent blood clots after procedures to open blocked heart arteries. Combining genetic testing, blood tests, and cost analysis, she aims to find out whether tailoring treatment to each patient’s genetic profile can improve outcomes while making better use of healthcare resources. She hopes her findings will support wider adoption of personalised medicine in Malaysia, so that patients receive treatments better suited to their individual needs.
In recognition of her research potential, Hafizah received the Merdeka Award Grant for International Attachment in 2025, which took her to leading institutions in Singapore, Thailand, and the Netherlands. There she learned from established pharmacogenomics services, gained practical laboratory experience, and worked with researchers and clinicians who are turning genetic discoveries into clinical practice.
She is also passionate about women’s health, particularly menstrual health and hygiene. As an undergraduate, she researched the menstrual health needs of female university students in Malaysia, adapting and validating a Malay-language questionnaire to help women better express their needs and challenges. The work, which aims to deepen understanding of women’s experiences and inform future health education, led to a first-author paper accepted for publication in BMC Women’s Health in 2026.
Hafizah has also shared her science through international conference presentations, public engagement, and science education initiatives. She hopes to bridge research, clinical practice, and healthcare policy so that scientific advances bring real benefits to patients and communities. Believing that where someone begins should not determine the impact they can make, she hopes to help build a future in which innovative, evidence-based healthcare reaches more Malaysians.

































